ASPN is thought to activate the SMAD2 pathway to induce EMT, as higher levels of phosphorylated SMAD2 have been observed in gastric cancer tissue compared with adjacent normal tissue [58] (Table 1). The gene discussed is ASPN; the disease is gastric cancer.